More frequent side effects include: dizziness, drowsiness, jaw pain, nausea, neck pain, paresthesia, sore throat, flushing sensation, and sensation of cold.  See below for a comprehensive list of adverse effects.
As well as its needed effects, zolmitriptan (the active ingredient contained in Zomig-ZMT) may cause unwanted side effects that require medical attention. 
Some zolmitriptan side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Common (1% to 10%): Chest pain/tightness/pressure and/or heaviness, neck/throat/jaw pain/tightness/pressure, palpitationsUncommon (0.1% to 1%): Arrhythmias, hypertension, syncope, tachycardia Rare (less than 0.1%): Angina pectoris, myocardial infarct, coronary vasospasm, QT prolongation, thrombophlebitis
Rare reports of serious cardiac adverse events have been reported including acute myocardial infarction within a few hours following administration of this drug.  Chest pain/tightness/pressure and/or heaviness appear to be dose-related occurring in 2%, 3%, and 4% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.  Neck/throat/jaw pain/tightness/pressure occurred in 4%, 7%, and 10% of patients, respectively.
Very Common (greater than 10%): Taste disturbances (up to 21%, inhaler)Common (1% to 10%): Paresthesia, somnolence, dizziness, hyperesthesiaRare (less than 0.1%): Cerebral ischemia, amnesia, convulsions, ataxia, dystonia, hyperkinesia, hypotonia, hypertoniaFrequency not reported: Serotonin syndrome
Paresthesia appears to be a dose-related adverse event occurring in 5%, 7%, and 9% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.
Common (1% to 10%): Warm/cold sensation, heaviness other than chest or neck, pressure/tightness/heaviness, vertigo, asthenia, chillsUncommon (0.1% to 1%): Tinnitus, hyperacusis, ear pain
Common (1% to 10%): Nausea, dry mouth, dysphagia, dyspepsia, abdominal pain, vomitingUncommon (0.1% to 1%): Gastroenteritis, increased thirstRare (less than 0.1%): Stomatitis, constipation, hematemesis, pancreatitis, melena, ulcer Very rare (less than 0.01%): Bloody diarrhea, gastrointestinal infarction or necrosis, gastrointestinal ischemic events, ischemic colitis, splenic infarction
The most common adverse reactions included neck, throat, jaw pain; dizziness; paresthesia; asthenia; somnolence; warm and cold sensation; nausea; heaviness sensation; and dry mouth.  In adolescents treated with the nasal spray, the more commonly reported adverse reactions included dysgeusia, nasal discomfort, dizziness, oropharyngeal pain, and nausea.
Uncommon (0.1% to 1%): ecchymosisRare (less than 0.1%): Thrombocytopenia, eosinophilia, leucopenia
Uncommon (0.1% to 1%): Increased appetite, thirstRare (less than 0.1%): Anorexia, hyperglycemia
Common (1% to 10%): Arthralgia, myalgia, muscle weakness Uncommon (0.1% to 1%): Back pain, leg cramps, tenosynovitisRare (less than 0.1%): Arthritis, tetanus, twitching
Common (1% to 10%): Disorder/discomfort of nasal cavity, throat pain, throat tightness, oropharyngeal painUncommon (0.1% to 1%): Pharyngitis, rhinitis, dyspnea, sinusitis, bronchitis, increased cough, epistaxis, laryngeal edema, hiccup, laryngitis, yawnRare (less than 0.1%): Apnea, voice alteration
Uncommon (0.1% to 1%): Allergic reactionsPostmarketing reports: Hypersensitivity reactions including angioedema, anaphylactic reactions and anaphylactic shock
Rare (less than 0.1%): Diplopia, dry eyes, lacrimation, conjunctivitis, eye pain, visual field defect
Uncommon (0.1% to 1%): Polyuria, urinary urgency, cystitis, hematuria Rare (less than 0.1%): Urinary frequency, miscarriage, dysmenorrhea
Common (1% to 10%): Sweating, facial edemaUncommon (0.1% to 1%): Urticaria, pruritus, rash, photosensitivity reactionRare (less than 0.1%): Angioedema
Common (1% to 10%): Local irritation or soreness at the site of administration of nasal spray
In clinical trials using the nasal spray approximately 3% (n=460) patients reported local irritation or soreness at the site of administration.  Effects were severe in about 1% of patients and approximately 57% resolved in 1 hour.  Nasopharyngeal examinations of a subset of patients failed to demonstrate any clinically significant changes with repeated use of the nasal spray.
It is possible that some side effects of Zomig-ZMT may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
nasal spray
Chest pain (severe)
heaviness, tightness, or pressure in the chest or neck
sensation of burning, warmth, heat, numbness, tightness, or tingling
Abdominal or stomach pain (severe)
changes in facial skin color
cough or hoarseness
diarrhea
fast or irregular heartbeat 
fever or chills
hives, itching, or skin rash
itching
loss of appetite
lower back or side pain
nausea
painful or difficult urination
puffiness or swelling of the eyelids or around the eyes, face, or lips
tightness in the chest
trouble breathing
weakness
Blurred vision
confusion
difficulty swallowing
dizziness
fainting
frequent strong or increased urge to urinate
headache
increased volume of pale, dilute urine
nervousness
pounding in the ears
severe numbness, especially on one side of the face or body
slow heartbeat
unusual tiredness or weakness
Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
Lack or loss of strength
sleepiness or unusual drowsiness
warm or cold sensation
Dizziness or lightheadedness
dry mouth
feeling of constant movement of self or surroundings
sensation of spinning
Anxiety
crying
depersonalization
depression
dysphoria
euphoria
hyperventilation
irritability
loss of memory
paranoia
problems with memory
quick to react or overreact emotionally
rapidly changing moods
redness of the skin
seeing, hearing, or feeling things that are not there
shaking
trouble sleeping
welts